Author | Ellen Kurek


Antipsychotic Increase Could Harm Mentally Ill TD Patients

October 21, 2017

An 18-year cohort study of severely mentally ill Afro-Caribbeans reported conflicting advisory from current tardive dyskinesia standards.

Rare Genetic Variant Linked to MS Risk, Vitamin D Levels

October 19, 2017

A rare variant of CYP2R1 doubles the risk of low vitamin D and increases MS risk by 40%.

Long-term Ingrezza Found Safe for Tardive Dyskinesia

October 13, 2017

Researchers gauged 3 pooled study results to consider the safety and tolerability of marketed valbenazine for TD.

Biomarkers Aid in Diagnosis, Prognosis of Early Multiple Sclerosis

October 11, 2017

Serum levels of interleukin-7 and C-X-C motif chemokine ligand 10 appeared to provide the most accurate means of identifying large differences in disease risk.